| Schedule of earnings (loss) per basic and diluted share |
|
|
|
Three months ended
September 30,
|
|
Nine months ended
September 30,
|
| |
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(6,083,670 |
)
|
|
$
|
(1,298,122 |
)
|
|
$
|
(12,944,628 |
)
|
|
$
|
(3,892,715 |
)
|
|
Less: deemed dividend for Earnout
Shares
|
|
|
(4,957,366 |
)
|
|
|
—
|
|
|
|
(4,957,366 |
)
|
|
|
—
|
|
|
Net loss attributable to common stockholders
|
|
$
|
(11,041,036 |
)
|
|
$
|
(1,298,122 |
)
|
|
$
|
(17,901,994 |
)
|
|
$
|
(3,892,715 |
)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used to compute basic and diluted EPS
|
|
|
16,535,661 |
|
|
|
9,637,962 |
|
|
|
11,983,183 |
|
|
|
9,637,962 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings (loss) per
share
|
|
$
|
(0.67 |
)
|
|
$
|
(0.13 |
)
|
|
$
|
(1.49 |
)
|
|
$
|
(0.40 |
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive securities excluded from shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
3,934,165 |
|
|
|
3,359,932 |
|
|
|
3,934,165 |
|
|
|
3,359,932 |
|
|
Warrants
|
|
|
18,722,425 |
|
|
|
—
|
|
|
|
18,722,425 |
|
|
|
—
|
|
|
Earnout shares
|
|
|
7,499,993 |
|
|
|
—
|
|
|
|
7,499,993 |
|
|
|
—
|
|
|
Debentures
|
|
|
2,922,425 |
|
|
|
—
|
|
|
|
2,922,425 |
|
|
|
—
|
|
|
Total
|
|
|
33,079,008 |
|
|
|
3,359,932 |
|
|
|
33,079,008 |
|
|
|
3,359,932 |
|
|
|
|
|
December 31,
|
| |
|
2021
|
|
2020
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(15,127,629 |
)
|
|
$
|
(7,194,038 |
)
|
|
Denominator
|
|
|
|
|
|
|
|
|
|
Weighted average shares used to compute basic EPS
|
|
|
678,406 |
|
|
|
678,400 |
|
|
Dilutive effect of stock-based awards
|
|
|
—
|
|
|
|
—
|
|
|
Weighted average shares used to compute diluted EPS
|
|
|
678,406 |
|
|
|
678,400 |
|
| |
|
|
|
|
|
|
|
|
|
Loss per share
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(22.30 |
)
|
|
$
|
(10.60 |
)
|
|
Diluted
|
|
$
|
(22.30 |
)
|
|
$
|
(10.60 |
)
|
|